ELICIO THERAPEUTICS I
5.0000
25-November-24 15:45:01
15 minutes delayed
Stocks
+0.0700
+1.42%
Today's range
4.9300 - 5.1000
ISIN
N/A
Source
NASDAQ
-
Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
05 Feb 2024 07:30:00 By Nasdaq GlobeNewswire
-
17 Jan 2024 07:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference
16 Jan 2024 07:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study
11 Jan 2024 07:30:00 By Nasdaq GlobeNewswire
-
09 Jan 2024 05:00:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Announces $7.0 Million Private Placement Financing
22 Dec 2023 08:00:32 By Nasdaq GlobeNewswire
-
04 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
09 Nov 2023 15:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Completes Reverse Merger and Provides a Corporate Update
06 Jun 2023 07:00:01 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Reports Inducement Grant to New Chief Financial Officer
02 Jun 2023 15:30:00 By Nasdaq GlobeNewswire
-
Elicio Therapeutics Announces Completion of Merger with Angion Biomedica
01 Jun 2023 15:04:00 By Nasdaq GlobeNewswire